Diem Nguyen

Diem Nguyen

Company: Xalud Therapeutics

Job title: CEO


Harnessing the Power of a DNA-Delivery Platform to Address Chronic Inflammatory Diseases 12:00 pm

Advantages of DNA-Delivery, including safety, potential flexibility and manufacturing efficiency Demonstration of functionality with XT-150, addressing critical areas where other delivery modalities of IL-10 therapy have been ineffective Clinical program results for XT-150, a novel immunomodulatory gene therapy for osteoarthritis pain in Phase 2B developmentRead more

day: Track B - Day 1 AM

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.